Puma Biotechnology Inc. (NYSE:PBYI)

CAPS Rating: 1 out of 5

Results 1 - 6 of 6

Recs

0
Member Avatar YourDailyBear (58.18) Submitted: 1/14/2016 1:28:07 PM : Underperform Start Price: $49.32 PBYI Score: +42.04

Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.

Recs

0
Member Avatar 1russianguy (50.16) Submitted: 8/20/2015 3:29:53 PM : Outperform Start Price: $88.32 PBYI Score: -66.01

Playing for a bounce from a correction.

Recs

0
Member Avatar TMFTypeoh (77.51) Submitted: 6/24/2015 11:57:47 AM : Outperform Start Price: $124.55 PBYI Score: -72.10

Pullback could be a decent entry point. Strong inside ownership.

Recs

0
Member Avatar CramersSkeeDaddy (97.91) Submitted: 7/23/2014 2:04:00 PM : Underperform Start Price: $232.10 PBYI Score: +90.40

up 300% in one day, enough said. Hopefully they do cure/treat all cancer but the short squeeze will likely end soon. No or little revenue, or earnings.

Recs

0
Member Avatar dabhsar (< 20) Submitted: 6/2/2013 8:56:29 AM : Outperform Start Price: $39.55 PBYI Score: -44.40

This small Bio Tech company is onto key medicine break through.

Recs

0
Member Avatar IBDContrarian (47.78) Submitted: 4/6/2013 1:50:39 PM : Underperform Start Price: $30.95 PBYI Score: +28.53

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MEDICAL 1 96 -- A- NO EARN

Results 1 - 6 of 6

Featured Broker Partners